Spirovant Sciences, a biotechnology company located in Philadelphia, is a leader in the development of gene therapies for cystic fibrosis (CF) and other lung diseases. Spirovant is focused on changing the course of cystic fibrosis and other pulmonary diseases. Our gene therapy technologies are designed to overcome the historical barriers that have prevented effective genetic treatments for cystic fibrosis. Spirovant has develo...
Spirovant Sciences, a biotechnology company located in Philadelphia, is a leader in the development of gene therapies for cystic fibrosis (CF) and other lung diseases. Spirovant is focused on changing the course of cystic fibrosis and other pulmonary diseases. Our gene therapy technologies are designed to overcome the historical barriers that have prevented effective genetic treatments for cystic fibrosis. Spirovant has developed a number of innovations in multiple viral vectors that collectively have the potential to overcome challenges that have previously limited the clinical viability of gene therapy for cystic fibrosis.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.